Bioconjugates: From Targets to Therapeutics 2015 is a conference dedicated to Transitioning Innovation into Viable Therapeutic Candidates.
Bioconjugates: From Targets to Therapeutics 2015 covers topics such as:
- Latest in ADC discovery and development
- New linkers, novel payloads and alternative binding modalities
- Advances beyond ADCs, including nanoparticle conjugations and bispecific conjugations
- Strategies for overcoming CMC and regulatory challenges
